Bayer Stock Crashes After Monsanto Cancer Verdict Upheld By Judge; Analyst Estimates $800 Billion In Future Liability | WHAT REALLY HAPPENED

Bayer Stock Crashes After Monsanto Cancer Verdict Upheld By Judge; Analyst Estimates $800 Billion In Future Liability

They’ve been waiting for the news about how San Francisco Superior Court Judge Suzanne Ramos Bolanos would rule in a certain case. Would she rule against or in favor of Bayer’s appeal of the Monsanto Cancer Verdict?

The case was finally resolved Tuesday morning. Judge Suzanne Ramos Bolanos upheld the jury’s decision, ruling that Roundup – a dangerous glyphosate-based weedkiller sold by Monsanto – lead to California man’s terminal cancer. She also ruled that Monsanto, in fact, intentionally hid the potential dangers of the weedkiller. (1)

Bayer had to know that such news would result in serious damage to the company. As the news of Judge Ramon Bolanos’ ruling spread like wildfire, it, of course, affected the stock market as well. The ruling resulted in an immediate crash in Bayer’s stock value.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA